Friday, August 10, 2018

Cipla arm secures marketing rights for cancer drug in US

Cipla arm secures marketing rights for cancer drug in US Capecitabine tablets are indicated in patients with colon cancer and for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy.

from Moneycontrol Business News https://ift.tt/2MAy0A4

No comments:

Post a Comment

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...